Skip to main content
SpringerLink
Log in

Maternal epilepsy and birth defects: A case-control study in the Italian Multicentric Registry of Birth Defects (IPIMC)

  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

A case control study on the association between maternal epilepsy, anticonvulsants use during pregnancy and birth defects was carried out in the Italian Multicentric Registry of Birth Defects (IPIMC).

In the period 1980–1983, 7,607 malformed babies out of 439,717 total births (still+live) were registered. Fourtyone malformed babies with maternal epilepsy were identified (5.39×1,000). The overall relative risk of having a malformed baby among pregnant epileptic women was 1.87.

Spina Bifida, Congenital Heart Defects, Clefts, Diaphragmatic Hernia and Trisomy 18 were more frequent than expected among babies with maternal epilepsy.

The different therapeutic regimens were also tested to identify the possible independent teratogenic effect of anticonvulsants. A statistically significant association between Spina Bifida and Valproic Acid (odds ratio 22.7; Fisher p value = 0.0364) was observed: no other anticonvulsant tested showed any association with any type of malformation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Anonymous (1981) : A communication from the International Clearinghouse for Birth Defects Monitoring Systems (ICBDMS). - Int. J. Epid. 10: 245–246.

    Google Scholar 

  2. Anonymous (1982): Valproate and Malformations.- Lancet, 2: 1313–1314.

  3. BjerkedalT. and BahnaL. (1973): The course and outcome of pregnancy in women with epilepsy. -Acta Obstet. Gynecol. Scand., 52: 245–248.

    Google Scholar 

  4. BjerkedalT., CzeizelA., GoujardJ. et al. (1982): Valproic Acid and Spina Bifida. - Lancet, 2: 1096.

    Article  CAS  Google Scholar 

  5. BossiL. (1983): Fetal effects of anticonvulsants. In: Antiepileptic drug therapy in Pediatric. MorselliP.L., PiffengerC.E. and PerryJ.K. Editors Raven Press. New York, pp. 37–64.

    Google Scholar 

  6. BrownN.A., KaoI. and FabroS. (1980): Teratogenic potential of Valproic Acid. - Lancet, 1: 660–661.

    Google Scholar 

  7. CornfieldJ. (1956): A statistical problem arising from retrospective studies. Proceedings of the 3rd Berkeley Symposium. - Berkeley: University of California Press, 4: 135–148.

    Google Scholar 

  8. ElshoveJ. and VanEckJ.H.M. (1971): Aageboren misvormingen, metname gesplaten lip met of zonder geslepten verhemeltes, by kindaren van moeders met epilepsie. - Med. Tijdschr. Geneeskd., 115: 1371–1375.

    Google Scholar 

  9. FisherR.A. (1956): Statistical methods and scientific inference. - Oliver and Boyd Press. London.

    Google Scholar 

  10. GomezM.R. (1981): Possible teratogenicity of Valproic Acid. - J. Pediatr., 98: 508–509.

    CAS  PubMed  Google Scholar 

  11. GoujardJ., HuelG. and Rumean-RoquetteC. (1974): Antiepileptiques et malformations congenitales. -J. Gynaecol. Obstet. Biol. Reprod., 3: 831–842.

    Google Scholar 

  12. HiilesmaaV.K., TeramoK. and GranstromM.L. (1981): Fetal head growth retardation associated with maternal entiepileptic drugs. - Lancet, 2: 165–167.

    Google Scholar 

  13. International Clearinghouse for Birth Defects Monitoring Systems (ICBDMS) (1984): Annaul Report 1982. Garnisonstryckeriet. Stockholm. Available from Sylvia Hay 4141 Twentieth Street-CA 94114 San Francisco.

  14. Italian League against Epilepsy (1984): Personal communication.

  15. JanzD. and FuchsU. (1964): Sind antiepileptische medikamente wahrend der schwangerschaft schadlich?- Dtsch. Med. Wochenschr., 89: 241–243.

    Google Scholar 

  16. JanzD. (1982): On major malformations and minor anomalies in the offspring of parents with epilepsy: review of literature. In: Epilepsy, pregnancy and the child. Janz D., Bossi L. and Schmidt D. Editors Raven Press, New York, pp. 211–222.

    Google Scholar 

  17. KoppeJ.G., BosmanW., OffersV.M. et al. (1973): Epilepsie en aangeboren afwijkingen. - Med. Tijdschr. Geeneskd., 117: 229–224.

    Google Scholar 

  18. KuenssbergE.V. and KnoxJ.D.E. (1973): Teratogenic effect of anticonvulsivants. - Lancet, 1: 198.

    Google Scholar 

  19. LoweC.R. (1983): Congenital malformations among infants born to epileptic women. - Lancet, 1: 9–10.

    Google Scholar 

  20. MacRaeK.D. (1982): Sodium Valproate and Neural Tube Defects. - Lancet, 2: 1282.

    Google Scholar 

  21. MastroiacovoP. (1984): The Italian Birth Defects Monitoring System: baseline rates based on 283,453 births and comparison with other Registries. In: Progress in Clinical and Biological Research, Volume 163B ≪Prevention of physical and mental congenital defects. Part. B: Epidemiology, early detection and therapy, and enviromental factors ≫. Maurice Marois, Editor. Bennet H.S., Brent R.L., Klingberg M.A., Lauder J. and Saxen L. Associate Editors. Alan R. Liss, Inc., New York.

    Google Scholar 

  22. MastroiacovoP., MusacchioP. and BertolliniR. (1982): L'Indagine Policentrica Italiana sulle Malformazioni Congenite (IPIMC). Un progetto collaborativo pilota finalizzato alla sprveglianza delle malformazioni congenite. - Prosp. in Pediatr., 45: 23–38.

    Google Scholar 

  23. MeadowS.R. (1968): Anticonvulsant drugs and congenital malformations. - Lancet, 2: 1296.

    Article  CAS  Google Scholar 

  24. MillerH.G.C. and NevinN.C. (1973): Congenital malformations and anticonvulsiant drugs. - Lancet, 1: 328.

    Google Scholar 

  25. NiswanderJ.D. and WerteleckiW. (1973): Congenital malformations among offspring of epileptic women. - Lancet; 1: 1062.

    Google Scholar 

  26. PaulsonG.W. and PaulsonR.B. (1981): Teratogenic effects of anticonvulsants. - Arch. NeurOl., 38: 140–143.

    Google Scholar 

  27. RallT.W. and SchleiferL.S. (1980): Drugs effective in the therapy of the epilepsies. In: The pharmachological basis of therapeutics. Goodman Gilman A., Goodman L.S. and Gilman A., Editors. Mac Millan Publishing Co., Inc., New York, p. 464.

    Google Scholar 

  28. RobertE. and GuibaudP. (1982): Maternal Valproic Acid and congenital Neural Tube Defects. -Lancet, 2: 937.

    Article  CAS  Google Scholar 

  29. RobertE. and RosaF. (1983): Valproate and Birth Defects. - Lancet, 2: 1142.

    Article  CAS  Google Scholar 

  30. RobertE., LofkvistE. and MouguireF. (1984): Valproate and Spina Bifida. - Lancet, 2: 1392.

    Google Scholar 

  31. ShapiroS., SloneD., HartzS.C. et al. (1976): Anticonvulsants and parental epilepsy in the development of birth defects. - Lancet, 1: 272–275.

    Google Scholar 

  32. SouthJ. (1972): Teratogenic effect of anticonvulsants.- Lancet, 2: 1154.

    Google Scholar 

  33. StanelyO.H. and ChambersT.L. (1982): Sodium Valproate and Neural Tube Defects. - Lancet, 2: 1282.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Regione Lazio, Unità di Epidemiologia, 00100, Roma

    R. Bertollini

  2. Istituto di Clinica Pediatrica, Università Cattolica del Sacro Cuore Largo A. Gemelli, 8, 00168, Rome

    P. Mastroiacovo & G. Segni

Authors
  1. R. Bertollini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Mastroiacovo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Segni
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bertollini, R., Mastroiacovo, P. & Segni, G. Maternal epilepsy and birth defects: A case-control study in the Italian Multicentric Registry of Birth Defects (IPIMC). Eur J Epidemiol 1, 67–72 (1985). https://doi.org/10.1007/BF00162315

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00162315

Key words

Search

Navigation